Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Vanda Pharmaceuticals (Nasdaq: VNDA) announced its upcoming participation in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025. The event will take place in New York City on Wednesday, May 21, 2025. This conference provides an opportunity for Vanda to engage with investors and discuss their developments in the neurological and ophthalmological therapeutic areas.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato la sua prossima partecipazione a incontri con investitori durante il Mizuho Neuro & Ophthalmology Summit 2025. L'evento si terr脿 a New York City mercoled矛 21 maggio 2025. Questa conferenza rappresenta un'occasione per Vanda di interagire con gli investitori e discutere i propri progressi nelle aree terapeutiche neurologiche e oftalmologiche.
Vanda Pharmaceuticals (Nasdaq: VNDA) anunci贸 su pr贸xima participaci贸n en reuniones con inversores en la Cumbre Mizuho Neuro & Ophthalmology 2025. El evento tendr谩 lugar en Nueva York el mi茅rcoles 21 de mayo de 2025. Esta conferencia ofrece una oportunidad para que Vanda se re煤na con inversores y discuta sus avances en las 谩reas terap茅uticas neurol贸gicas y oftalmol贸gicas.
Vanda Pharmaceuticals (雮橃姢雼�: VNDA)臧赌 2025雲� 氙胳順� 鞁犼步 氚� 鞎堦臣 靹滊皨鞐愳劀 韴瀽鞛� 氙疙寘鞐� 彀胳棳頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 鞚� 頄夓偓電� 2025雲� 5鞗� 21鞚� 靾橃殧鞚�, 雺挫殨鞁�鞐愳劀 臧滌禍霅╇媹雼�. 鞚措矆 須岇潣電� Vanda臧� 韴瀽鞛愲摛瓿� 靻岉喌頃橁碃 鞁犼步頃� 氚� 鞎堦臣 旃橂 攵勳暭鞚� 臧滊皽 順勴櫓鞚� 雲检潣頃� 靾� 鞛堧姅 旮绊殞毳� 鞝滉车頃╇媹雼�.
Vanda Pharmaceuticals (Nasdaq : VNDA) a annonc茅 sa prochaine participation aux rencontres avec les investisseurs lors du Mizuho Neuro & Ophthalmology Summit 2025. L'茅v茅nement se d茅roulera 脿 New York City le mercredi 21 mai 2025. Cette conf茅rence offre 脿 Vanda une occasion d'茅changer avec les investisseurs et de pr茅senter ses avanc茅es dans les domaines th茅rapeutiques neurologiques et ophtalmologiques.
Vanda Pharmaceuticals (Nasdaq: VNDA) gab seine bevorstehende Teilnahme an Investorenmeetings beim Mizuho Neuro & Ophthalmology Summit 2025 bekannt. Die Veranstaltung findet am Mittwoch, den 21. Mai 2025 in New York City statt. Diese Konferenz bietet Vanda die M枚glichkeit, mit Investoren in Kontakt zu treten und 眉ber ihre Entwicklungen in den neurologischen und ophthalmologischen Therapiegebieten zu sprechen.
- None.
- None.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit 聽and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]
View original content to download multimedia:
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) participating in the Mizuho Neuro & Ophthalmology Summit 2025?
Where is the Mizuho Neuro & Ophthalmology Summit 2025 being held?
What type of meetings will VNDA participate in at the Mizuho Summit 2025?
What is the stock symbol for Vanda Pharmaceuticals?
